FATE THERAPEUTICS INC Income Statement
FATE|13 years of annual SEC 10-K data (FY2013-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 13 fiscal years. All figures from audited SEC 10-K filings.
FATE THERAPEUTICS INC reported $14M in revenue and $186M in net loss for FY2025. Revenue has grown at a 22.7% compound annual rate over the past 12 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 632.81 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.6M | $63.5M | $96.3M | $31.4M | $10.7M | $4.7M | $4.1M | $4.4M | - | $1.3M | $971.0K | $2.7M | $1.2M |
| SG&A Expense | $74.2M | $81.4M | $84.2M | $33.9M | $23.6M | $15.8M | $11.9M | $9.9M | $10.4M | $8.5M | $6.6M | $4.2M | $4.6M |
| R&D Expense | $135.0M | $172.6M | $320.5M | $125.6M | $87.8M | $56.0M | $34.4M | $26.5M | $19.9M | $16.4M | $12.0M | $12.0M | $9.9M |
| Operating Income | -$210.3M | -$190.5M | -$308.4M | -$128.1M | -$100.7M | -$67.1M | -$42.1M | -$32.0M | -$27.8M | -$24.9M | -$17.7M | -$13.6M | -$13.3M |
| Interest Expense | - | - | - | - | $1.8M | $1.7M | $1.3M | $1.6M | $2.2M | $549.0K | $796.0K | $487.0K | $127.0K |
| Income Tax | $0 | $0 | $0 | $0 | $0 | - | - | - | - | - | - | - | - |
| Net Income | -$186.3M | -$160.9M | -$281.7M | -$173.4M | -$98.1M | -$66.6M | -$43.0M | -$33.5M | -$30.0M | -$25.9M | -$20.9M | -$14.2M | -$1.2M |
| EPS (Basic) | -$1.64 | -$1.64 | -$2.91 | -$2.10 | - | - | - | - | - | - | - | - | - |
| EPS (Diluted) | -$1.64 | -$1.64 | -$2.91 | -$2.10 | -$1.44 | -$1.19 | -$1.02 | -$1.05 | -$1.18 | -$1.27 | -$3.54 | -$13.06 | -$16.16 |
| Shares Outstanding | 113.9M | 98.6M | 97.3M | 95.7M | 87.7M | 75.7M | 64.7M | 52.6M | 41.4M | 28.7M | 20.6M | 20.4M | 1.3M |
| Operating Margin | -1542.6% | -299.9% | -320.2% | -407.5% | -943.1% | -1415.4% | -1025.9% | -726.1% | - | -1883.8% | -1820.3% | -507.7% | -1136.1% |
| Profit Margin | -1366.5% | -253.3% | -292.6% | -551.6% | -919.0% | -1405.0% | -1046.1% | -760.1% | - | -1957.9% | -2151.8% | -533.3% | -104.6% |